当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • Jゲートを開く
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • 電子ジャーナルライブラリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • 仮想生物学図書館 (vifabio)
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

Palliation in Advanced Heart Failure: Identifying Barriers in Malaysia

Raja Shariff REF, Katiman D, Wen LC and Kasim SS

Introduction: An estimated 26 million people worldwide suffer from the heart failure, and more than half of new diagnosis is made in those aged 80 years and above. Furthermore, nearly 75% have at least one other comorbidity. Advanced heart failure, defined as ‘advanced and persistent heart failure with symptoms at rest despite repeat attempts to optimize pharmacological and non-pharmacological therapy carry with it further problems including repeated hospitalizations, poor quality of life, disability and symptom burden, as well as reliance on intravenous support or device therapy, all of which have direct implications to both patients and their loved ones.

Objective: We explore the possible barriers that exist in initiating palliation in advanced heart failure patients, unique to an Asian and Malaysian population.

Discussion: We first explore the universal barriers towards palliation, including those revolving around limited evidence specifically surrounding heart failure palliation, communication breakdown, and accessibility and service provision limitation. We then explore specific barriers unique to Malaysia, surrounding its core value of being a multicultural, multi-faith nation.

Conclusion: Discussions surrounding heart failure palliation and palliative care remains taboo amongst patients and physicians. Heart failure remains an enigma and is often unpredictable in its course which leads to physician reluctance in discussing poor outcomes with patients. By understanding the barriers that exist, including that of culture and religion, we now know that early discussions and continuous involvement of both patients and their relatives in decision making may be the key in end-of-life care in advanced heart failure.